Fidelity Investments’s Acumen Pharmaceuticals ABOS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.35M | Buy |
2,029,736
+4,113
| +0.2% | +$4.77K | ﹤0.01% | 2438 |
|
|
2025
Q1 | $2.23M | Buy |
2,025,623
+1,863
| +0.1% | +$2.05K | ﹤0.01% | 2409 |
|
|
2024
Q4 | $3.48M | Sell |
2,023,760
-4,357
| -0.2% | -$7.49K | ﹤0.01% | 2273 |
|
|
2024
Q3 | $5.03M | Buy |
2,028,117
+6,014
| +0.3% | +$14.9K | ﹤0.01% | 2125 |
|
|
2024
Q2 | $4.89M | Sell |
2,022,103
-66,897
| -3% | -$162K | ﹤0.01% | 2084 |
|
|
2024
Q1 | $8.46M | Buy |
+2,089,000
| New | +$8.46M | ﹤0.01% | 1925 |
|
|
2023
Q4 | – | Sell |
-657
| Closed | -$2.73K | – | 5416 |
|
|
2023
Q3 | $2.73K | Buy |
657
+180
| +38% | +$747 | ﹤0.01% | 4466 |
|
|
2023
Q2 | $2.29K | Sell |
477
-202
| -30% | -$971 | ﹤0.01% | 4558 |
|
|
2023
Q1 | $2.76K | Sell |
679
-220
| -24% | -$893 | ﹤0.01% | 4546 |
|
|
2022
Q4 | $4.86K | Hold |
899
| – | – | ﹤0.01% | 4265 |
|
|
2022
Q3 | $9K | Hold |
899
| – | – | ﹤0.01% | 4108 |
|
|
2022
Q2 | $4K | Sell |
899
-939
| -51% | -$4.18K | ﹤0.01% | 4353 |
|
|
2022
Q1 | $7K | Sell |
1,838
-11,462
| -86% | -$43.7K | ﹤0.01% | 4322 |
|
|
2021
Q4 | $90K | Sell |
13,300
-93,800
| -88% | -$635K | ﹤0.01% | 3109 |
|
|
2021
Q3 | $1.59M | Buy |
+107,100
| New | +$1.59M | ﹤0.01% | 2619 |
|